The Important Role of Chemotherapy in the Treatment of Breast Cancer

Abstract

Breast cancer is the most commonly diagnosed cancer among women worldwide and a leading cause of cancer-related mortality. Chemotherapy has historically been a cornerstone in breast cancer management, particularly in high-risk or aggressive forms of the disease. This thesis aims to investigate the role chemotherapy plays across various stages of breast cancer and its integration into modern therapeutic protocols. Chemotherapy for breast cancer is used in two main settings. ‍First, upfront as part of a curative treatment for non-metastatic cancer, either before surgery or after surgery. The second use for chemotherapy is in the metastatic setting, once a tumor has left the breast and has gotten into other organs in the body. To be clear, not all patients develop metastases, and therefore not all patients who get chemotherapy experience it in both of these scenarios. The idea is to use chemotherapy upfront to prevent the second metastatic scenario from ever happening.  To illustrate the use of chemotherapy as part of a curative upfront treatment, let's look at a woman who has a large tumor in the breast.  It's large enough that its removal immediately would require probably a mastectomy because it's too big for a lumpectomy to leave a reasonably good cosmetic result. Chemotherapy is started before surgery, and the tumor shrinks. Sometimes this allows for a lumpectomy instead of a mastectomy, but it also gives a good trial of chemotherapy to see how that tumor responds to treatment in that patient. This can be very useful if the patient needs additional chemotherapy down the road.